LivaNova PLC Share-based Payment Arrangement, Expense, after Tax
LivaNova PLC (LIVN) reported Share-based Payment Arrangement, Expense, after Tax of $33.48 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2026-02-25
- LivaNova PLC share-based payment arrangement, expense, after tax for the quarter ending 2016-12-31 was $3.15M.
- LivaNova PLC share-based payment arrangement, expense, after tax for the quarter ending 2016-09-30 was $3.94M, a 63.09% decline year-over-year.
- LivaNova PLC share-based payment arrangement, expense, after tax for the quarter ending 2016-06-30 was $2.33M, a 9.37% decline year-over-year.
- LivaNova PLC share-based payment arrangement, expense, after tax for the quarter ending 2016-03-31 was $5.50M, a 253.60% increase year-over-year.
- LivaNova PLC share-based payment arrangement, expense, after tax for fiscal 2025 was $33.48M, a 6.96% increase from fiscal 2024.
- LivaNova PLC share-based payment arrangement, expense, after tax for fiscal 2024 was $31.30M, a 9.29% decline from fiscal 2023.
- LivaNova PLC share-based payment arrangement, expense, after tax for fiscal 2023 was $34.51M, a 21.76% decline from fiscal 2022.
- LivaNova PLC share-based payment arrangement, expense, after tax for fiscal 2022 was $44.10M, a 10.32% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, after Tax 3 month | Share-based Payment Arrangement, Expense, after Tax 3 month as first filed | Share-based Payment Arrangement, Expense, after Tax 6 month | Share-based Payment Arrangement, Expense, after Tax 8 month | Share-based Payment Arrangement, Expense, after Tax 8 month as first filed | Share-based Payment Arrangement, Expense, after Tax 9 month | Share-based Payment Arrangement, Expense, after Tax 12 month | Share-based Payment Arrangement, Expense, after Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $33.48M 10-K · filed 2026-02-25 | |||||||
| 2024-12-31 | $31.30M 10-K · filed 2026-02-25 | |||||||
| 2023-12-31 | $34.51M 10-K · filed 2026-02-25 | |||||||
| 2022-12-31 | $44.10M 10-K · filed 2025-02-25 | |||||||
| 2021-12-31 | $39.98M 10-K · filed 2024-02-29 | |||||||
| 2020-12-31 | $34.10M 10-K · filed 2023-02-27 | |||||||
| 2019-12-31 | $25.96M 10-K · filed 2022-03-01 | |||||||
| 2018-12-31 | $20.48M 10-K · filed 2021-03-01 | |||||||
| 2017-12-31 | $14.83M 10-K · filed 2020-03-02 | |||||||
| 2016-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $7.09M derived: sum of 2 quarters · filed 2019-03-18 | $9.42M derived: sum of 3 quarters · filed 2019-03-18 | $14.92M 10-K · filed 2019-03-18 | $14.36M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $3.94M 10-Q · filed 2016-11-02 | $6.27M derived: sum of 2 quarters · filed 2016-11-02 | $11.77M 10-Q · filed 2016-11-02 | |||||
| 2016-06-30 | $2.33M 10-Q · filed 2016-08-05 | $7.83M 10-Q · filed 2016-08-05 | ||||||
| 2016-03-31 | $5.50M 10-Q · filed 2016-05-09 | |||||||
| 2015-12-31 | $23.25M 10-K · filed 2018-02-28 | $23.17M 10-K · filed 2017-03-01 | ||||||
| 2015-10-18 | $10.66M 10-Q · filed 2016-11-02 | $10.66M 10-Q · filed 2015-12-02 | $13.23M 10-Q · filed 2015-12-08 | $14.79M 10-Q · filed 2016-11-02 | ||||
| 2015-07-24 | $2.57M 10-Q · filed 2016-08-05 | $4.13M 10-Q · filed 2016-08-05 | ||||||
| 2015-04-24 | $1.56M 10-Q · filed 2016-05-09 | $8.00M 10-K · filed 2018-02-28 | ||||||
| 2014-10-24 | $1.71M 10-Q · filed 2015-12-08 | $4.36M 10-Q · filed 2015-12-08 | ||||||
| 2014-04-25 | $7.50M 10-K · filed 2017-03-01 | |||||||
| 2013-04-26 | $7.87M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |